Current status: Answered by Angela Constance on 10 July 2026
To ask the Scottish Government what discussions it has had with the UK Government regarding any assessment it has made of any implications of the UK–US trade deal for the pricing of new medicines in Scotland, including the potential impact on NHS Scotland's budget.
Whilst the UK Government is yet to share any detailed impact assessment with Scottish Ministers, we are continuing to work closely with the UK Government to assess the costs and benefits of the deal, including the implications of recently announced implementation measures and pilot programmes.
When the impact assessments are made available, we will consider the implications the price changes for medicines will have on the NHS in Scotland.